Effectiveness of a Treatment With the Robot - Assisted Gait Training System Walkbot in Patients With Cerebral Palsy
NCT ID: NCT04329793
Last Updated: 2021-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2019-04-08
2021-03-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There are some studies that evaluate walking interventions on treadmill with partial weight support, on the ground and in assisted walking robot in patients with PC.
Currently, there are no studies conducted that report the effectiveness of interventions performed with robotic walking training device Walkbot K on PC. However, studies in adults with Walkbot S, affected with neurological injury, have reported good results.
Assisted gait training with robotic devices such as the Walkbot, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions. However, due to the little evidence that exists, it is necessary to know the effectiveness of the Walkbot assisted walking robot in these patients by means of a clinical trial that allows to firmly establish the scope of its benefits.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
NCT02391324
Innovative Robotic Gait Trainer Use to Enable Walking in Children With Cerebral Palsy GMFCS III and IV
NCT05378243
Study Aims to Compare the Effect of Robotic-assisted Gait Training and Conventional Treadmill Training on Postural Stability in Ambulatory Children With Cerebral Palsy.
NCT06719271
Muscle Synergies During Gait in Children With Cerebral Palsy Undergoing Robot-assisted Gait Therapy
NCT06156969
Evaluating Wearable Robotic Assistance on Gait
NCT04119063
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention arm
Assisted gait training with Walkbot System and their usual Physical Therapy.
Assisted gait training with Walkbot System
The experimental group will receive at least 3 treatment sessions per week consisting of 40 minutes in robot-assisted gait training with Walkbot System in addition to their usual Physical therapy sessions. In total, the number of Walkbot sessions will be 20, in uninterrupted weeks.
Physical Therapy
The control group will receive their usual Physical therapy sessions during 6 weeks.
Control arm
Their usual Physical Therapy.
Physical Therapy
The control group will receive their usual Physical therapy sessions during 6 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assisted gait training with Walkbot System
The experimental group will receive at least 3 treatment sessions per week consisting of 40 minutes in robot-assisted gait training with Walkbot System in addition to their usual Physical therapy sessions. In total, the number of Walkbot sessions will be 20, in uninterrupted weeks.
Physical Therapy
The control group will receive their usual Physical therapy sessions during 6 weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to communicate even if not verbal (yes/not; gestures; pictograms; sounds)
* Levels II, III and IV in GMFCS
* Unsupported seating capacity
* Go on standing with or without help
* Not receiving therapy with a walking robot and not having received it in at least one year
Exclusion Criteria
* Serious heart problems
* Active tumors
* Severe joint degenerative problems
* Degenerative diseases of the nervous system
* Mitochondrial diseases
* Recent surgeries
* Unbound fractures
* Severe osteoporosis
* Uncontrolled seizures
* Open wounds in the lower half of the body
* Extreme fear of being placed in robotic devices
* Anthropomorphic measures are below the minimum required to use the device
3 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raquel Olmos Gómez
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Raquel Olmos Gómez
Yecla, Murcia, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Olmos-Gomez R, Calvo-Munoz I, Gomez-Conesa A. Treatment with robot-assisted gait trainer Walkbot along with physiotherapy vs. isolated physiotherapy in children and adolescents with cerebral palsy. Experimental study. BMC Neurol. 2024 Jul 15;24(1):245. doi: 10.1186/s12883-024-03750-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2365/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.